SEC Form 4 · accession 0001209191-18-062939
PhaseBio Pharmaceuticals Inc · PHAS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David James Ballance
Officer — VP, Research and Sci. Affairs
Period of report
Dec 13, 2018
Accepted (ET)
Dec 17, 2018 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169245
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 13, 2018 | P | 1,000 | $3.94 | A | 7,600 | D |
Table II — derivative securities
No Table II lines on this filing.